135 related articles for article (PubMed ID: 10777666)
1. Molecular characterization of germline NF2 gene rearrangements.
Legoix P; Sarkissian HD; Cazes L; Giraud S; Sor F; Rouleau GA; Lenoir G; Thomas G; Zucman-Rossi J
Genomics; 2000 Apr; 65(1):62-6. PubMed ID: 10777666
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of 16 polymorphic markers in the NF2 gene: application to hemizygosity detection.
Legoix P; Legrand MF; Ollagnon E; Lenoir G; Thomas G; Zucman-Rossi J
Hum Mutat; 1999; 13(4):290-3. PubMed ID: 10220142
[TBL] [Abstract][Full Text] [Related]
3. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
4. Large intragenic deletions of the NF2 gene: breakpoints and associated phenotypes.
Abo-Dalo B; Kutsche K; Mautner V; Kluwe L
Genes Chromosomes Cancer; 2010 Feb; 49(2):171-5. PubMed ID: 19924781
[TBL] [Abstract][Full Text] [Related]
5. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
6. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
[TBL] [Abstract][Full Text] [Related]
7. A point mutation associated with a severe phenotype of neurofibromatosis 2.
MacCollin M; Braverman N; Viskochil D; Ruttledge M; Davis K; Ojemann R; Gusella J; Parry DM
Ann Neurol; 1996 Sep; 40(3):440-5. PubMed ID: 8797533
[TBL] [Abstract][Full Text] [Related]
8. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination?
Hiltunen M; Helisalmi S; Mannermaa A; Alafuzoff I; Koivisto AM; Lehtovirta M; Pirskanen M; Sulkava R; Verkkoniemi A; Soininen H
Eur J Hum Genet; 2000 Apr; 8(4):259-66. PubMed ID: 10854108
[TBL] [Abstract][Full Text] [Related]
11. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.
Rouleau GA; Merel P; Lutchman M; Sanson M; Zucman J; Marineau C; Hoang-Xuan K; Demczuk S; Desmaze C; Plougastel B
Nature; 1993 Jun; 363(6429):515-21. PubMed ID: 8379998
[TBL] [Abstract][Full Text] [Related]
12. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
Kley N; Seizinger BR
Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
[TBL] [Abstract][Full Text] [Related]
13. Detection of novel NF2 mutations by an RNA mismatch cleavage method.
Faudoa R; Xue Z; Lee F; Baser ME; Hung G
Hum Mutat; 2000; 15(5):474-8. PubMed ID: 10790209
[TBL] [Abstract][Full Text] [Related]
14. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
Buckley PG; Mantripragada KK; Díaz de Ståhl T; Piotrowski A; Hansson CM; Kiss H; Vetrie D; Ernberg IT; Nordenskjöld M; Bolund L; Sainio M; Rouleau GA; Niimura M; Wallace AJ; Evans DG; Grigelionis G; Menzel U; Dumanski JP
Hum Mutat; 2005 Dec; 26(6):540-9. PubMed ID: 16287142
[TBL] [Abstract][Full Text] [Related]
15. Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.
Diebold R; Bartelt-Kirbach B; Evans DG; Kaufmann D; Hanemann CO
J Mol Diagn; 2005 Feb; 7(1):97-104. PubMed ID: 15681480
[TBL] [Abstract][Full Text] [Related]
16. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH.
Bruder CE; Hirvelä C; Tapia-Paez I; Fransson I; Segraves R; Hamilton G; Zhang XX; Evans DG; Wallace AJ; Baser ME; Zucman-Rossi J; Hergersberg M; Boltshauser E; Papi L; Rouleau GA; Poptodorov G; Jordanova A; Rask-Andersen H; Kluwe L; Mautner V; Sainio M; Hung G; Mathiesen T; Möller C; Pulst SM; Harder H; Heiberg A; Honda M; Niimura M; Sahlén S; Blennow E; Albertson DG; Pinkel D; Dumanski JP
Hum Mol Genet; 2001 Feb; 10(3):271-82. PubMed ID: 11159946
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer.
Belogianni I; Apessos A; Mihalatos M; Razi E; Labropoulos S; Petounis A; Gaki V; Keramopoulos A; Pandis N; Kyriacou K; Hadjisavvas A; Kosmidis P; Yannoukakos D; Nasioulas G
BMC Cancer; 2004 Sep; 4():61. PubMed ID: 15353005
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
Kim JH; Kim IS; Kwon SY; Jang BC; Suh SI; Shin DH; Jeon CH; Son EI; Kim SP
Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152
[TBL] [Abstract][Full Text] [Related]
19. [Development and establishment of a yeast-based stop codon assay for detection of NF2 gene premature-terminating mutations].
Kobayashi H
Hokkaido Igaku Zasshi; 1999 Sep; 74(5):377-86. PubMed ID: 10495852
[TBL] [Abstract][Full Text] [Related]
20. Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development.
Huynh DP; Tran TM; Nechiporuk T; Pulst SM
Cell Growth Differ; 1996 Nov; 7(11):1551-61. PubMed ID: 8930405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
